Dr Reddy's launches oral suspension drug in the US market

The newly launched product is in the strengths of 0.8 g and 2.4 g packets, and is a therapeutic equivalent generic version of Renvela (sevelamer carbonate) for oral suspension.

from Healthcare/Biotech-Industry-Economic Times http://bit.ly/2VaNoI2
via IFTTT